Revenue | ₹652.30Cr |
Net Profits | ₹136.96Cr |
Net Profit Margins | 21% |
Alivus Life Sciences Ltd’s revenue jumped 13.54% since last year same period to ₹652.30Cr in the Q3 2024-2025. On a quarterly growth basis, Alivus Life Sciences Ltd has generated 26.56% jump in its revenue since last 3-months.
Alivus Life Sciences Ltd’s net profit jumped 15.32% since last year same period to ₹136.96Cr in the Q3 2024-2025. On a quarterly growth basis, Alivus Life Sciences Ltd has generated 43.68% jump in its net profits since last 3-months.
Alivus Life Sciences Ltd’s net profit margin jumped 1.56% since last year same period to 21% in the Q3 2024-2025. On a quarterly growth basis, Alivus Life Sciences Ltd has generated 13.53% jump in its net profit margins since last 3-months.
The revenue for Alivus Life Sciences Ltd in the Q3 results 2024 was ₹652.30Cr.
The net profit for Alivus Life Sciences Ltd in the Q3 results 2024 was ₹136.96Cr.
The net profit margin for Alivus Life Sciences Ltd in the Q3 results 2024 was 21%.
The revenue for Alivus Life Sciences Ltd in the Q3 results 2023 was ₹574.50Cr.
The net profit for Alivus Life Sciences Ltd in the Q3 results 2023 was ₹118.77Cr.
The net profit margin for Alivus Life Sciences Ltd in the Q3 results 2023 was 20.67%.